• 1. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

4-Chloro-2-(pyrrolidin-1-yl)-1,3-thiazole-5-carboxylic Acid: A Comprehensive Overview

4-Chloro-2-(pyrrolidin-1-yl)-1,3-thiazole-5-carboxylic acid, also known by its CAS registry number CAS No. 1211296-57-9, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of thiazole derivatives, which have been extensively studied for their diverse biological activities. The structure of this compound features a thiazole ring system substituted with a chlorine atom at position 4 and a pyrrolidine group at position 2, along with a carboxylic acid moiety at position 5. These structural elements contribute to its unique chemical properties and potential applications in drug discovery.

The synthesis of 4-Chloro-2-(pyrrolidin-1-yl)-1,3-thiazole-5-carboxylic acid typically involves multi-step organic reactions. The process often starts with the preparation of the thiazole core, followed by functionalization at specific positions to introduce the substituents. Recent advancements in synthetic methodologies have enabled the efficient construction of such complex structures with high purity and yield. Researchers have explored various strategies, including nucleophilic substitution, coupling reactions, and cyclization processes, to optimize the synthesis pathway for this compound.

The biological activity of 4-Chloro-2-(pyrrolidin-1-yl)-1,3-thiazole-5-carboxylic acid has been a focal point of recent studies. This compound has demonstrated potential as a modulator of various cellular pathways, making it a promising candidate for therapeutic applications. For instance, studies have shown that it exhibits significant anti-inflammatory properties by inhibiting key enzymes involved in inflammatory responses. Additionally, its ability to modulate ion channels and receptors suggests its potential role in treating neurological disorders.

In terms of pharmacokinetics, 4-Chloro-2-(pyrrolidin-1-y) has shown favorable absorption and bioavailability profiles in preclinical models. This attribute is crucial for its development as an orally administered drug. Furthermore, its metabolic stability and low toxicity profiles have been highlighted in recent toxicity studies, indicating its suitability for long-term therapeutic use.

The application of computational chemistry tools has greatly enhanced our understanding of the molecular interactions of this compound. Molecular docking studies have revealed that it binds effectively to target proteins with high affinity, providing insights into its mechanism of action. These findings have been corroborated by experimental data from in vitro assays, further validating its potential as a lead compound in drug development.

Recent research has also explored the use of 4-Chloro-thiazole derivatives in combination therapies to enhance efficacy and reduce adverse effects. By leveraging the unique properties of this compound, researchers aim to develop novel treatment strategies for conditions such as chronic inflammation and neurodegenerative diseases.

In conclusion, CAS No. 1211296-57-9, or 4-Chloro-< strong >thiazole derivative strong > , represents a compelling candidate for advancing drug discovery efforts. Its versatile structure and promising biological profile make it an area of continued research interest. As ongoing studies unravel more about its mechanisms and applications, this compound holds the potential to contribute significantly to the development of innovative therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)